Private equity firms are drawing political fire on the campaign trail and on Capitol Hill, where lawmakers on Tuesday sparred over whether new rules are needed to contend with the investment vehicles' growing role in the U.S. economy.
Record numbers of generic drugs for cancer, heart ailments and other conditions have received U.S. approval in recent years, raising hopes that the new competition would reduce high drug costs. But many of the lower-price medicines haven’t hit the market, a Wall Street Journal review found.
Carl Armato, chief executive and president of Novant Health Inc., received a 5.2% increase in salary during fiscal 2018 to $1.5 million, the health system reported Friday. Armato’s incentive pay increased 4 percent to $1.33 million.
While the total number of people affected isn’t being made public, numerous Californians with both healthcare and long-term care coverage are being hit with similar charges. “It isn’t right,” said Bonnie Burns, a policy specialist with California Health Advocates, a Sacramento nonprofit organization.
We have an affordability crisis in healthcare, and everyone should be working to bring down costs for patients. But as a new report outlines, many doctors and drugmakers have developed the coziest of relationships to keep drug costs high for their benefit.
West Virginia University Medicine, the state’s largest medical system and biggest private employer, continues to expand its footprint in an effort to offer patients greater access the highest level of health care available.